Gregory B. Brown

Founder at Healthcare Royalty Management LLC

Gregory B. Brown

Gregory B. Brown

Founder at Healthcare Royalty Management LLC

Overview
Career Highlights

Healthcare Royalty Management LLC

RelSci Relationships

425

Number of Boards

10

Birthday

1954

Age

66

Contact Data
Trying to get in touch with Gregory B. Brown? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Gregory B. Brown likely has professional access to. A relationship does not necessarily indicate a personal connection.

Managing Director at Cowen Healthcare Royalty Management LLC

Relationship likelihood: Strong

Founder at Healthcare Royalty Management LLC

Relationship likelihood: Strong

President at Frank M. Armstrong Consulting Ltd.

Relationship likelihood: Strong

Operating Partner at Madryn Asset Management LP

Relationship likelihood: Strong

President & Chief Executive Officer at Caladrius Biosciences, Inc.

Relationship likelihood: Strong

Partner at Healthcare Royalty Management LLC

Relationship likelihood: Strong

Partner & Chief Medical Officer at Healthcare Royalty Management LLC

Relationship likelihood: Strong

Former Director, President, Chief Executive Officer & Chief Operating Officer at Cambrex Corp.

Relationship likelihood: Strong

Chief Executive Officer & Founder at Faron Pharmaceuticals Oy

Relationship likelihood: Strong

President & Chief Executive Officer at AcuFocus, Inc.

Relationship likelihood: Strong

Paths to Gregory B. Brown
Potential Connections via
Relationship Science
You
Gregory B. Brown
Founder at Healthcare Royalty Management LLC
Education
MD
Class of 1979

SUNY Upstate Medical University in Syracuse, NY, is the only academic medical center in Central New York. It is also the region's largest employer with 9,460 employees. Affiliated with the State University of New York, Upstate's mission is to improve the health of the community through education, biomedical research and health care. Upstate Medical University's educational mission is anchored by its four colleges—Medicine, Nursing, Health Professions and Graduate Studies (biomedical sciences). Since 2006, student enrollment has grown by 30% as Upstate responds to the needs of the region.

AB

Yale University is an American private Ivy League research university located in New Haven, Connecticut. Founded in 1701 in the Colony of Connecticut, the university is the third-oldest institution of higher education in the United States.

The oldest corporation in the Western Hemisphere is the Harvard Corporation, known formally as the President and Fellows of Harvard College. It is the smaller of Harvard’s two governing boards; the other is the Board of Overseers. Following are the members of the Harvard Corporation.

M.B.A.

Harvard Business School (HBS) is the graduate business school of Harvard University in Boston, Massachusetts, United States. The school offers a large full-time MBA program, doctoral programs, and many executive education programs. It owns Harvard Business School Publishing, which publishes business books, leadership articles, online management tools for corporate learning, case studies, and the monthly Harvard Business Review.

Career History
Founder
2007 - ?

Healthcare Royalty Management invests primarily in commercial stage healthcare companies, pharmaceutical, biotechnology and products through the purchase of traditional passive royalties, the creation of synthetic royalties, structured debt and equity instruments. The firm focus on healthcare companies and products across a broad range of therapeutic areas predominately in the US and European Union. They targets investments of $20 million to $200 million. They provides financing capital to assist in the transfer of product and execution risk, finance new development opportunities, acquire new products or technologies, fund additional capital needs and monetize product royalties.

Partner
2003 - 2006

Paul Capital Partners' investment platforms include the Paul Capital Fund of Funds, secondary investments and commercial-stage healthcare investments.The Paul Capital Fund of Funds investment team focuses on investments in venture capital and small-cap buyouts. The firm invests in funds that support innovative products and business models. They take takes a lead investment role and actively seek advisory board seats. Their strategy is both growth and value oriented.The Paul Capital Fund of Funds venture capital investment strategy focuses on providing access to top-tier venture capital managers. The firm looks for emerging managers that have the potential to become industry leaders. They employ a multi-industry investment strategy that focuses on information technology, healthcare and clean technology. Most investments are made in early-stage companies, but some investments are made in late-stage and growth equity to provide reduced volatility and more rapid exits. The strategy is biased towards small funds and is balanced by a short list of larger funds or platforms. Paul Capital invests primarily in funds in the Silicon Valley and Boston, with growing exposure to select international investments. They make secondary investments in top tier managers obtained through the secondary market to mitigate the effect of the typical J-Curve associated with private equity fund investing.The Paul Capital Fund of Funds small-cap buyout investment strategy focuses on investments in a small-cap buyout funds in North America. They invest in small-cap buyout funds that are being raised by managers who are focused on buying companies with enterprise values of $300 million or less. To select the best performing managers, Paul Capital's process begins with a large universe of buyout relationships and ends with a focused and diversified small-cap buyout portfolio. The portfolio is complemented by co-investments and by investments in target funds obtained through the secondary market.The Paul Capital Fund of Funds co-investment strategy focuses on co-investments alongside general partners that are well-known to the firm and who require capital to close pending small-cap buyout and growth equity transactions. Investments are made directly in the securities of the portfolio company. The Fund of Funds team invests directly in portfolio companies across a full range of economic and credit cycles.For investors requiring exposure to both the firm's venture capital and small-cap buyout funds, Paul Capital provides customized solutions that allow participation in both activities over a multi-year period with a desired percentage allocation to each. Large investors seeking increased exposure to emerging managers, growth equity funds or buyout funds larger than their small-cap target (but generally less than $2 billion in size) can be accommodated through a separate account relationship.Paul Capital provides secondary transaction solutions for various sellers including pension plans, financial institutions, endowments, family offices, corporations and general partners.They help sellers reallocate their portfolio across asset types and classes, achieve early liquidity from private equity investments and obtain follow-on capital for existing portfolios and other objectives.Paul Capital Healthcare employs a variety of financing options ranging from non-dilutive financings that include royalty and revenue interest financings, to more traditional instruments such as equity and structured debt. Their clients include public and private companies, academic institutions and inventors. Paul Capital Healthcare helps companies monetize their royalty streams by selling all or a portion of these future royalties in exchange for an upfront payment and, depending on the structure, potential future payments. Paul Capital Healthcare invests in healthcare products that are approved and are generating revenue or are near commercialization. Healthcare companies should have an identifiable and established market, have patent and/or regulatory protection and be marketed by a strong organization.Paul Capital Healthcare employs the use of synthetic royalties or revenue interest financings. The firm provides a company with an upfront payment and future payments in exchange for a percentage of future product revenues. These deals are structured in a way that is similar to licensing agreements. They employ tiered revenues, reverse tiers, minimum payments, caps, step-downs and buy-out options. The deals are different from a standard licensing agreement in that Paul Capital Healthcare is not responsible for commercializing the product and is not involved in the company's daily operations. The firm makes an upfront payment to the company and, in some cases, additional payments based on certain milestones, such as regulatory approvals, patent extensions and sales targets. Paul Capital Healthcare then receives a portion of the future revenues generated by the product(s).Paul Capital Healthcare provides structured debt financing for small to mid-sized healthcare companies looking to expand operations. They can structure mezzanine-like debt in combination with revenue interests or royalty financings and the purchase of equities.Paul Capital Healthcare also structures traditional equity investments, usually in combination with revenue interest and royalty financings. The Fund participates in early-stage financing rounds in syndication with venture funds and in PIPE-style offerings. Paul Capital Healthcare focuses on near market or commercial-stage investments.

Head-Investment Banking & Healthcare
1997 - 2002

Part of Canaccord Genuity Group, Inc., Adams Harkness & Hill Investment Banking is an American company located in Boston, MA, specializing in investment advice.

Boards & Committees
Director
2006 - Current

Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded in 1961 and is headquartered in Waltham, MA.

Political Donations
$20K
2012

Senator at Office of the Senator from Utah, Mitt Romney

$500
2012

The Republican National Committee (RNC) is a U.S. political committee that provides national leadership for the Republican Party of the United States. It is responsible for developing and promoting the Republican political platform, as well as coordinating fundraising and election strategy. It is also responsible for organizing and running the Republican National Convention. Similar committees exist in every U.S. state and most U.S. counties, although in some states party organization is structured by congressional district, allied campaign organizations being governed by a national committee. Reince Priebus is the current RNC Chairman.

$250
2011

Former Governor of Utah

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Gregory B. Brown. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Gregory B. Brown's profile does not indicate a business or promotional relationship of any kind between RelSci and Gregory B. Brown.